Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neolytica is a private healthcare analytics and software company focused on serving biopharma organizations with AI- and data science-driven tools for key opinion leader mapping, healthcare professional targeting, sentiment analysis, and stakeholder intelligence. The company operates as a subsidiary or division of QPharma and positions itself as a bridge between medical affairs, commercial, market access, and sales functions. Its core offerings include the Ti Expert platform and NotifyMe, which support KOL influence mapping, social listening, message impact assessment, and next-best-action insights. Neolytica appears to be a commercial-stage health technology company rather than a therapeutics developer, with no disclosed drug pipeline or clinical programs. The business is oriented toward enabling pharmaceutical and biotech customers to improve engagement strategy, launch planning, and compliant cross-functional decision-making.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neolytica.